Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 29 2 2020
medline: 9 7 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Microdosing psychedelics - the practice of consuming small, sub-hallucinogenic doses of substances such as LSD or psilocybin - is gaining attention in popular media but remains poorly characterized. Contemporary studies of psychedelic microdosing have yet to report the basic psychiatric descriptors of psychedelic microdosers. To examine the practices and demographics of a population of psychedelic microdosers - including their psychiatric diagnoses, prescription medications, and recreational substance use patterns - to develop a foundation on which to conduct future clinical research. Participants ( Of microdosers, most reported using LSD (59.3%; M Well-designed randomized controlled trials are needed to evaluate the safety and tolerability of this practice in clinical populations and to test claims about potential benefits.

Identifiants

pubmed: 32108529
doi: 10.1177/0269881120908004
doi:

Substances chimiques

Hallucinogens 0
Psilocybin 2RV7212BP0
Lysergic Acid Diethylamide 8NA5SWF92O

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

612-622

Auteurs

Daniel Rosenbaum (D)

Psychiatry, University of Toronto Faculty of Medicine, Toronto, Canada.

Cory Weissman (C)

Psychiatry, University of Toronto Faculty of Medicine, Toronto, Canada.

Thomas Anderson (T)

Psychology, University of Toronto, Toronto, Canada.

Rotem Petranker (R)

Psychology, York University, Toronto, Canada.

Le-Anh Dinh-Williams (LA)

Clinical Science, University of Toronto, Scarborough, Canada.

Katrina Hui (K)

Psychiatry, University of Toronto Faculty of Medicine, Toronto, Canada.

Emma Hapke (E)

Psychiatry, University of Toronto Faculty of Medicine, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH